XTL Biopharmaceuticals
(NASDAQ:XTLB)
1.7399
0.0099[0.57%]
At close: May 23
1.88
0.1401[8.05%]
After Hours: 4:35PM EDT
Day High/Low1.74 - 1.84
52 Week High/Low1.48 - 6.69
Open / Close1.84 / 1.82
Float / Outstanding- / 5.4M
Vol / Avg.0.6K / 6.6K
Mkt Cap9.5M
P/E25.19
50d Avg. Price2.16
Div / Yield-
Payout Ratio-
EPS0.4
Total Float-

XTL Biopharmaceuticals (NASDAQ:XTLB), Quotes and News Summary

XTL Biopharmaceuticals (NASDAQ: XTLB)

Day High/Low1.74 - 1.84
52 Week High/Low1.48 - 6.69
Open / Close1.84 / 1.82
Float / Outstanding- / 5.4M
Vol / Avg.0.6K / 6.6K
Mkt Cap9.5M
P/E25.19
50d Avg. Price2.16
Div / Yield-
Payout Ratio-
EPS0.4
Total Float-
load more
Sector: Health Care.Industry: Biotechnology
XTL Biopharmaceuticals Ltd is engaged in the field of healthcare. It is a pharmaceutical manufacturer, with a focus on acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

Earnings

see more
Q3 2018Est.ActualSurprise
EPS0.004
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

XTL Biopharmaceuticals Questions & Answers

Q
How do I buy XTL Biopharmaceuticals (XTLB) stock?
A

You can purchase shares of XTL Biopharmaceuticals (NASDAQ: XTLB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are XTL Biopharmaceuticals's (XTLB) competitors?
Q
What is the target price for XTL Biopharmaceuticals (XTLB) stock?
A

The latest price target for XTL Biopharmaceuticals (NASDAQ: XTLB) was reported by HC Wainwright & Co. on Friday, May 8, 2015. The analyst firm set a price target for 6.00 expecting XTLB to rise to within 12 months (a possible 244.85% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for XTL Biopharmaceuticals (XTLB)?
A

The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $1.7399 last updated May 23, 2022, 7:22 PM UTC.

Q
Does XTL Biopharmaceuticals (XTLB) pay a dividend?
A

There are no upcoming dividends for XTL Biopharmaceuticals.

Q
When is XTL Biopharmaceuticals (NASDAQ:XTLB) reporting earnings?
A

XTL Biopharmaceuticals’s Q3 earnings are confirmed for Thursday, November 1, 2018.

Q
Is XTL Biopharmaceuticals (XTLB) going to split?
A

There is no upcoming split for XTL Biopharmaceuticals.

Q
What sector and industry does XTL Biopharmaceuticals (XTLB) operate in?
A

XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.